Press Releases | Medtronic

Month Year

Email alerts

Nov 22, 2016

Medtronic Reports Second Quarter Financial Results

Revenue of $7.3 Billion Grew 4% as Reported; 3% at Constant Currency

DUBLIN - November 22, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2017, which ended October 28, 2016. The company reported second...
Nov 17, 2016

New Data Show Medtronic Heli-FX EndoAnchor System Enhances Outcomes and Durability in Complex Aortic Disease

Data from ANCHOR Registry Demonstrate Applicability in Patients with Hostile Aortic Neck Anatomy

DUBLIN and NEW YORK - Nov. 17, 2016 - Medtronic plc (NYSE: MDT) today announced data demonstrating that the company's Heli-FX(TM) EndoAnchor(TM) system enhances outcomes and durability in patients...
Nov 16, 2016

Medtronic's Solitaire(TM) Stent Retriever Device Receives Expanded Indication from the U.S. Food and Drug Administration for the Reduction of Stroke-Related Disability

FDA Allows Use of the Most Studied Stent Retriever with IV-tPA

DUBLIN - Nov. 16, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded indication for the Solitaire(TM) stent retriever device....
Nov 16, 2016

Medtronic Releases FY16 Integrated Performance Report

Report Highlights Company's Global Financial, Social, and Environmental Impact

DUBLIN - Nov. 16, 2016 - Medtronic plc (NYSE:MDT) announces the release of its 2016 Integrated Performance Report. The report highlights - for the first time - the combined financial, social, and...
Nov 15, 2016

Medtronic's Endurant(TM) II/IIs Stent Graft System Delivers Positive Outcomes in Patients with Challenging Aortic Aneurysms

New Data from the Global ENGAGE Registry Builds on Durability of Endurant, with Strong Outcomes Out to Four Years in Patients with Standard and Hostile Neck Anatomies

DUBLIN - Nov. 15, 2016 - Medtronic plc (NYSE:MDT) today announced data supporting the strength and durability of the Endurant(TM) II/IIs1 stent graft system to treat abdominal aortic aneurysm...
Nov 14, 2016

Medtronic Receives FDA Approval for Claria MRI(TM) Quad Cardiac Resynchronization Therapy Defibrillator

First CRT-D in U.S. to Help Improve Therapy Delivery in Heart Failure Patients Using Effective Pacing

DUBLIN - Nov. 14, 2016 - Medtronic plc (NYSE:MDT) has received U.S. Food and Drug Administration (FDA) approval for the Claria MRI(TM) Quad Cardiac Resynchronization Therapy Defibrillator (CRT-D)...
Nov 14, 2016

Medtronic to Unveil Data Supporting Endovascular Treatments for Aortic Disease at VEITHsymposium 2016

DUBLIN - Nov. 14, 2016 - Medtronic plc (NYSE: MDT) today announced notable presentations of clinical studies on how endovascular treatments are furthering the treatment of core and complex aortic...
Nov 11, 2016

Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2017

DUBLIN - Nov. 11, 2016 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for its second quarter of fiscal year 2017 on Tuesday, November 22, 2016. A news release...
Nov 10, 2016

Medtronic Launches Orthopedic Solutions Business to Help Providers Deliver Outcome-Focused Care and Succeed in New Value-Based Bundled Service Models

Orthopedic Solutions Offers Comprehensive Services for Joint Replacement Episodes of Care, Including the Launch of a Total Knee Arthroplasty System

DUBLIN and DALLAS - Nov. 10, 2016 - Medtronic plc (NYSE: MDT) today announced the launch of Medtronic Orthopedic Solutions, a comprehensive offering for total joint replacement episodes of care...
Nov 1, 2016

Medtronic CoreValve(TM) Evolut R(TM) System Shows Exceptional Clinical Outcomes at One Year

New Data from Evolut R U.S. IDE study presented at TCT Reveals Positive Clinical Performance for the Recapturable TAVR Device, Including the First-of-its-Kind 34 mm Valve

DUBLIN and WASHINGTON, D.C. - Nov. 1, 2016 - Medtronic plc (NYSE: MDT) unveiled new clinical data showing that patients treated with the self-expanding CoreValve(TM) Evolut(TM) R System continued...
Nov 1, 2016

Medtronic Harmony(TM) Transcatheter Pulmonary Valve Demonstrates Positive Early Clinical Outcomes at One Year

FDA Approves IDE Study Initiation Following Positive Results from First-of-its-Kind Early Feasibility Study Presented at TCT

DUBLIN and WASHINGTON, D.C. - Nov. 1, 2016 - Medtronic plc (NYSE: MDT) today announced new clinical data for the Harmony(TM) Transcatheter Pulmonary Valve (TPV) from its early feasibility study,...
Oct 31, 2016

New Data on Medtronic Evolut(TM) R TAVR System Show Excellent 'Real-World' Outcomes in Global Patient Population

Results from FORWARD and STS/ACC TVT Registry Demonstrate High Survival and Low Rate of All Stroke for Next-Generation TAVR Device in Everyday Clinical Practice

DUBLIN and WASHINGTON, DC - Oct. 31, 2016 - Medtronic plc (NYSE: MDT) today presented new positive data from two large registries aimed at evaluating 30-day clinical performance outcomes for the...
Oct 31, 2016

First Clinical Data of Medtronic Drug-Filled Stent Show Positive Outcomes

Featured 'First Report' RevElution Trial at TCT Highlights the Potential Benefits of First-of-its-Kind Polymer-Free Technology with Controlled and Sustained Drug Delivery for Rapid Vessel Healing

DUBLIN and WASHINGTON, D.C. - Oct. 31, 2016 - Medtronic plc (NYSE: MDT) unveiled today the first clinical outcomes of its novel Drug-Filled Stent (DFS) from the RevElution Trial at the...
Oct 30, 2016

Independent Study Finds Biodegradable Polymer Stents Provide No Clinical Benefit Over Resolute Integrity(TM) DES

BIO-RESORT Demonstrates Excellent Clinical Outcomes for Medtronic Resolute(TM) Integrity(TM) DES, a Gold Standard for Percutaneous Coronary Intervention

DUBLIN and WASHINGTON, DC - Oct. 30, 2016 - Investigators today unveiled clinical data from the independent BIO-RESORT study, representing the first all-comers analysis to compare the safety and...
Oct 27, 2016

The World Stroke Organization Road Map for Quality Stroke Care Has Been Launched

Medtronic joins the Global Framework for Stroke Care on World Stroke Day

DUBLIN and HYDERABAD, India - Oct. 27, 2016 - In recognition of World Stroke Day, Medtronic plc (NYSE:MDT) and the World Stroke Organization (WSO) joined together for the third year to raise...
Oct 26, 2016

Medtronic Announces FDA Approval of New Recaptureable TAVR System Available for Severe Aortic Stenosis Patients with Large Anatomies

Launch of 34 mm Self-Expanding Evolut R Device Expands TAVR Treatment to Patients Who Could Not be Treated Previously

DUBLIN - Oct. 26, 2016 - Medtronic plc (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the CoreValve(TM) Evolut(TM) R 34 mm valve-the largest...
Oct 24, 2016

MiniMed® Connect Mobile Accessory for Android Now Available from Medtronic

MiniMed Connect Mobile Accessory Provides Easier and Better Access to Pump and CGM Data, Helping Optimize Therapy for Improved Glycemic Patterns

DUBLIN - October 24, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced U.S. commercial availability of the Android(TM) operating system version of the...
Oct 24, 2016

Medtronic Receives FDA Clearance of New Lower Profile HawkOne 6F Directional Atherectomy System

New Technology Expands Treatment Options for Patients with Peripheral Artery Disease Both Above and Below the Knee

DUBLIN - Oct. 24, 2016 - Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the HawkOne(TM) Directional Atherectomy System in a new size for...
Oct 21, 2016

Medtronic to Webcast Investor and Analyst Briefings on October 26, 2016 and October 30, 2016

DUBLIN - Oct. 21, 2016 - Medtronic plc (NYSE:MDT) today announced the company will webcast investor and analyst briefings at two upcoming medical conferences. Medtronic will host a webcast to...
Oct 14, 2016

Medtronic Announces Voluntary Recall of Its Pipeline(TM) Embolization Device, Alligator(TM) Retrieval Device, X-Celerator(TM) Hydrophilic Guidewire, Ultraflow(TM) and Marathon(TM) Flow Directed Micro Catheters

DUBLIN - Oct. 14, 2016 - Medtronic plc (NYSE: MDT) today announced that it has notified customers of a voluntary recall of certain lots of its Pipeline(TM) embolization device, Alligator(TM)...
Oct 13, 2016

FIRE AND ICE Analysis: Lower Healthcare System Costs with Medtronic Cryoballoon

Late Breaking Clinical Trial Demonstrates Favorable Health Economics and Positive Clinical Outcomes for AF Patients

DUBLIN AND SEOUL, REPUBLIC OF KOREA - Oct. 13, 2016 - Medtronic plc (NYSE:MDT) today unveiled new health economic analysis data from the FIRE AND ICE trial that favor cryoballoon catheter ablation...
Oct 13, 2016

Medtronic Cardiac Devices Gain FDA Approval to Enable Patient Access to the Most Advanced Diagnostic Imaging

Patients with SureScan® Pacemakers, ICDs and CRT-Ds Now Can Receive 3 Tesla MRI Scans

DUBLIN - Oct. 13, 2016 - Medtronic plc (NYSE:MDT) is the first company to receive U.S. Food and Drug Administration (FDA) approval for its suite of cardiac rhythm and heart failure devices and...
Oct 3, 2016

Medtronic Avalus(TM) Surgical Aortic Valve Shows Positive Outcomes in One-Year Clinical Trial Results

Presented at EACTS, First Data of New Pericardial Heart Valve Finds High Survival and Excellent Hemodynamics

DUBLIN and BARCELONA - Oct. 3, 2016 - Medtronic plc (NYSE: MDT) today announced positive clinical data for its investigational Avalus(TM) pericardial aortic surgical valve, intended for the...
Sep 30, 2016

FDA Classifies Two Field Actions Related to HeartWare HVAD System as Class 1 Recalls

DUBLIN - Sept. 30, 2016 - Medtronic plc (NYSE:MDT) announced today that two previously communicated global voluntary recalls related to the HeartWare International (HeartWare) HVAD® System have...
Sep 28, 2016

Medtronic Receives FDA Clearance of TrailBlazer Angled Peripheral Support Catheter

TrailBlazer Angled Support Catheter Broadens Medtronic's Leading Peripheral Options Adding Full Spectrum of Angled Resources to Meet Provider Needs

DUBLIN - September 28, 2016 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) has cleared the TrailBlazer(TM) angled support catheter for use in the...

Show per page